Bronchiolitis-associated hospitalizations among US children, 1980-1996

JAMA

Volumn 282, Issue 15, 1999, Pages 1440-1446

  Shay, David K ^a,d   Holman, Robert C ^a   Newman, Robert D ^b   Liu, Lenna L ^b   Stout, James W ^b,c   Anderson, Larry J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BRONCHIOLITIS; CHILD; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFANT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; REINFECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS;

EID: 0032696770     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.15.1440     Document Type: Article

References (53)

1. Parrott RH, Kim HW, Arrobio JO, et al. Epidemiology of respiratory syncytial virus infectons in Washington DC, II. Am J Epidemiol. 1973;98:289-300.
2. Institute of Medicine. The prospects for immunizing against respiratory syncytial virus. In: New Vaccine Development Establishing Priorities. Vol 2. Washington, DC: National Academy Press; 1986:299-307.
3. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. AJDC. 1986;140:543-546.
4. Henderson FW, Collier AM, Clyde WA, et al. Respiratory-syncytial virus infections: reinfections and immunity. N Engl J Med. 1979;300:530-534.
5. Research Council Subcommittee on respiratory syncytial virus vaccines. Respiratory syncytial virus infection: admissions to hospital in industrial, urban, and rural areas. BMJ. 1978;2:796-798.
6. Kim HW, Arrobio JO, Brandt CD, et al. Epidemiology of respiratory syncytial virus infections in Washington, DC, I: importance of the virus in different respiratory tract disease syndromes and temporal distribution of infections. Am J Epidemiol. 1973;98:216-225.
7. Sims DC, Downham MA, McQuillin J, Gardner PS. Respiratory syncytial virus infection in north-east England. BMJ. 1976;2:1095-1098.
8. Caul EO, Waller DK, Clarke SK. A comparison of influenza and respiratory syncytial virus infections among infants admitted to hospital with acute respiratory tract infections. J Hyg. 1976;77:383-392.
9. Saijo M, Ishii T, Kokubo M, Takimoto M, Takahashi Y. Respiratory syncytial virus infection in lower respiratory tract and asthma attack in hospitalized children in North Hokkaido, Japan. Acta Paediatr Jpn. 1993;35:233-237.
10. Yun B, Kim M, Park J, Choi E, Lee H, Yun C. Viral etiology and epidemiology of acute lower respiratory tract infections in Korean children. Pediatr Infect Dis J. 1995;14:1054-1059.
11. Dagan R, Landau D, Haikin H, Tal A. Hospitalization of Jewish and Bedouin infants in southern Israel for bronchiolitis caused by respiratory syncytial virus. Pediatr Infect Dis J. 1993;12:381-386.
12. Brandt CD, Kim HW, Arrobio JO, et al. Epidemiology of respiratory syncytial virus infection in Washington, DC, III. Am I Epidemiol. 1973;98:355-364.
13. Hall CB. Respiratory syncytial virus. In: Feigin RD, Cherry JD, eds. Textbookof Pediatric Infectious Diseases. 4th ed. Philadelphia, Pa: WB Saunders Co; 1998:2087.
14. Institute of Medicine. Prospects for Immunizing against respiratory syncytial virus. In: New Vaccine Development: Establishing Priorities. Vol 1. Washington, DC: National Academy Press; 1985:397-409.
15. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998; 102:531-537.
16. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IVIG. Pediatrics. 1998;102:1211-1216.
17. Hall CB. Prospects for a respiratory syncytial virus vaccine. Science. 1994;265:1393-1394.
18. Murphy BR, Collins PL. Current status of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccine development. Bull World Health Organ. 1997;75:307-313.
19. Karron RA, Wright PF, Crowe JE Jr, et al. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. J Infect Dis. 1997;176:1428-1436.
20. National Center for Health Statistics. National Hospital Discharge Survey: Multi-Year Data Tape Information, 1979-96. Hyattsville, Md: National Center for Health Statistics; 1998.
21. Graves EJ, Kozak LJ. National Hospital Discharge Survey: annual summary, 1996. Vital Health Stat 13. 1999;140:i-iv, 1-46.
22. Gillium BS, Graves EJ, Jean L. Trends in hospital utilization: United States, 1988-92. Vital Health Stat 13. 124;1996:1-71.
23. US Public Health Service and Health Care Financing Administration. International Classification of Diseases, Ninth Revision, Clinical Modification. 6th ed. [CD-ROM]. Hyattsville, Md: Centers for Disease Control and Prevention; 1998.
24. Gardner PS, Court SD, Brocklebank JT, et al. Virus cross-infection in paediatric wards. MBJ. 1973;2: 571-575.
25. Hall CB, Douglas RG, Geiman JM, et al. Nosocomial respiratory syncytial virus infections. N Engl J Med. 1975;293:1343-1346.
26. US Bureau of the Census. Intercensal Estimates of the Population by Age, Sex, and Race: 1970-1996. Washington, DC: US Bureau of the Census; 1998.
27. Kozak LJ. Underreporting of Race in the National Hospital Discharge Survey. Hyattsville, Md: National Center for Health Statistics; July 6, 1995. Advance Data From Vital and Health Statistics, No. 265, pp 1-12.
28. US Department of Health and Human Services. Detailed Data 1979-96: Public Use Data Tape Documentation: Natality. Hyattsville, Md: Centers for Disease Control and Prevention, National Center for Health Statistics; 1998.
29. Haupt BJ, Kozak LJ. Estimates from two survey designs. Vital Health Stat 13. 1992;111:1-75.
30. Shah BV, Bamell BG, Bieler GS. SUDAAN User's Manual, Release 7.0. Research Triangle Park, NC: Research Triangle Institute; 1996.
31. Sirken MG, Shimizu BI, French DK, Brock DB. Manual on Standards and Procedures for Reviewing Statistical Reports. Hyattsville, Md. National Center for Health Statistics; 1992.
32. Anderson LJ, Heirholzer JC, Tson C, et al. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J. Infect Dis. 1985;151:626-633.
33. McConnochie KM, Hall CB, Walsh EE, Roghmann KT. Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr. 1990;162: 1283-1290.
34. Walsh EE, McConnochie KM, Long CE, Hall CB. Severity of respiratory virus infection is related to virus strain. J Infect Dis. 1997;175:814-820.
35. Hall CB, Walsh EE, Schnabel KC, et al. Occurrence of groups A and B of respiratory syncytial virus over 15 years. J Infect Dis. 1990;162:1283-1290.
36. Anderson LJ, Hendry RM, Pierik LT, Tsou C, McIntosh K. Multicenter study of strains of respiratory syncytial virus. J Infect Dis. 1991;163:687-692.
37. Peret TC, Hall CB, Schnabel KC, Golub JA, Anderson LJ. Circulation patterns of genetically distinct group A and B strains of respiratory syncytial virus in a community. J Gen Virol. 1998;79:2221-2229.
38. Anderson LJ, Parker RA, Strikas RA, et al. Day care attendance and hospitalization for lower respiratory tract illness. Pediatrics. 1988;82:300-308.
39. Hofferth SL. Child care in the United States today. Future Child. 1996;6:41-61.
40. Yamamoto LG, MacPherson KA, Miller NC, et al. Changes in the treatment of wheezing children in the emergency department. Am J Emerg Med. 1993;11:109-114.
41. Maneker AJ, Petrack EM, Krug SE. Contribution of routine pulse oximetry to evaluation and management of patients with respiratory illness in a pediatric emergency department. Ann Emerg Med. 1995;25:36-40.
42. Crain EF, Weiss KB, Fagan MJ. Pediatric asthma care in US emergency departments. Arch Pediatr Adolesc Med. 1995;149:893-901.
43. Law BJ, De Carvalho V, for the Pediatric Investigators Collaborative Network on Infections in Canada. Respiratory syncytial virus infections in hospitalized Canadian children. Pediatr Infect Dis J. 1993;12:659-663.
44. McIntosh ED, De Silva L, Oates RK. Clinical severity of respiratory syncytial virus group A and B infection in Sydney, Australia. Pediatr Infect Dis J. 1993; 12:815-819.
45. Hall CB, Douglas RG Jr. Clinically useful method for the isolation of respiratory syncytial virus. J Infect Dis. 1975;131:1-5.
46. Singleton RJ, Petersen KM, Berner JE, et al. Hospitalizations for respiratory syncytial virus infection in Alaska Native children. Pediatr Infect Dis J. 1995;14:26-30.
47. Glezen WP. Incidence of respiratory syncytial and parainfluenza type 3 viruses in urban settings. Pediatr Virol. 1987;2:1-4.
48. Glezen WP. Pathogenesis of bronchiolitis - epidemiologic considerations. Pediatr Res. 1977;11:239-243.
49. Glezen WP, Paredes A, Allison JE, et al. Risk of respiratory syncytial virus infection from low-income families in relationship age, sex, ethnic group and maternal antibody group. J Pediatr. 1981;98:708-715.
50. Foy HM, Cooney MK, Maletzky AJ, et al. Incidence and etiology of pneumonia, croup, and bronchiolitis in preschool children belonging to a prepaid medical group over a four-year period. Am J Epidemiol. 1973;97:80-92.
51. Monto AS, Lim SK. The Tecumseh study of respiratory illness, III: incidence and periodicity of respiratory syncytial virus and Mycoplasma pneumoniae infections. Am J Epidemiol. 1971;94:290-301.
52. Gilchrist S, Török TJ, Gary HE Jr, Alexander JP, Anderson LJ. National surveillance for respiratory syncytial virus, United States, 1985-1990. J Infect Dis. 1994;170:986-990.
53. Centers for Disease Control and Prevention. Update: respiratory syncytial virus activity - United States, 1997-98 season. MMWR Morb Mortal Wkly Rep. 1997;46:1163-1165.